ATE390121T1 - Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator - Google Patents

Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator

Info

Publication number
ATE390121T1
ATE390121T1 AT02771959T AT02771959T ATE390121T1 AT E390121 T1 ATE390121 T1 AT E390121T1 AT 02771959 T AT02771959 T AT 02771959T AT 02771959 T AT02771959 T AT 02771959T AT E390121 T1 ATE390121 T1 AT E390121T1
Authority
AT
Austria
Prior art keywords
phospholipides
photosensitiser
compositions containing
micelle compositions
containing pegylated
Prior art date
Application number
AT02771959T
Other languages
English (en)
Inventor
Theresa Allen
Ronald Boch
Anthony Boey
Original Assignee
Univ Alberta
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta, Quadra Logic Tech Inc filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE390121T1 publication Critical patent/ATE390121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT02771959T 2001-11-02 2002-11-01 Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator ATE390121T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33788401P 2001-11-02 2001-11-02

Publications (1)

Publication Number Publication Date
ATE390121T1 true ATE390121T1 (de) 2008-04-15

Family

ID=23322426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02771959T ATE390121T1 (de) 2001-11-02 2002-11-01 Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator

Country Status (8)

Country Link
US (1) US20040013717A1 (de)
EP (1) EP1465590B1 (de)
AT (1) ATE390121T1 (de)
AU (1) AU2002336867A1 (de)
CA (1) CA2466103C (de)
DE (1) DE60225844T2 (de)
ES (1) ES2306785T3 (de)
WO (1) WO2003037295A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003230761A1 (en) * 2002-03-29 2003-10-13 Abbott Laboratories Polymeric micelle formulations of hydrophobic compounds and methods
US20040116360A1 (en) * 2002-10-15 2004-06-17 Kwon Glen S. Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles
WO2009065065A1 (en) * 2007-11-15 2009-05-22 Ceramoptec Industries, Inc. Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
US20100255080A1 (en) * 2009-04-02 2010-10-07 Sesvalia Usa, Llc Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment
CA2849367A1 (en) * 2011-09-22 2013-03-28 3M Innovative Properties Company Thermally insulated components for exhaust systems
US20140377180A1 (en) * 2013-06-24 2014-12-25 Canon Kabushiki Kaisha Photoacoustic contrast agent having lipid particle containing silicon naphthalocyanine analog
KR101554564B1 (ko) 2013-11-22 2015-09-21 한국과학기술원 암 질환의 진단 또는 치료용 마이셀 구조의 나노 제제 및 이의 제조방법
KR101681299B1 (ko) * 2013-12-27 2016-12-05 한국과학기술원 빌리루빈 나노입자, 이의 용도 및 제조방법
US20190224332A1 (en) 2016-09-07 2019-07-25 Cadila Healthcare Limited Sterile injectable compositions comprising drug micelles

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5620689A (en) * 1989-10-20 1997-04-15 Sequus Pharmaceuuticals, Inc. Liposomes for treatment of B-cell and T-cell disorders
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
GB9502065D0 (en) * 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
US6375930B2 (en) * 1996-06-04 2002-04-23 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
RU2186562C2 (ru) * 1996-08-22 2002-08-10 Ресеч Трайангл Фармасьютикалс Лтд. Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
HU224176B1 (hu) * 1997-05-07 2005-06-28 The University Of British Columbia A benzoporfirinszármazék fotoaktív vegyületek új osztálya
CZ294715B6 (cs) * 1997-05-07 2005-02-16 Qlt Inc. Ethylenglykol estery monohydrobenzoporfyrinových derivátů jako fotoaktivní činidla
US20050025819A1 (en) * 1997-07-14 2005-02-03 Hayat Onyuksel Materials and methods for making improved micelle compositions
EP1206288B1 (de) * 1999-08-02 2007-01-10 The Regents Of The University Of Michigan Zielgerichtete fiberlose radiative effektoren
US6949620B2 (en) * 2000-01-26 2005-09-27 Japan Science And Technology Corporation Polymeric micellar structure
DE60110057T2 (de) * 2000-01-28 2005-09-08 Alza Corp., Mountain View Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung
CA2408323C (en) * 2000-05-08 2012-06-12 The University Of British Columbia Drug delivery systems for photodynamic therapy
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US20060216342A1 (en) * 2003-04-18 2006-09-28 Torchilin Vladimir P Micelle delivery system loaded with a pharmaceutical agent
US20060251795A1 (en) * 2005-05-05 2006-11-09 Boris Kobrin Controlled vapor deposition of biocompatible coatings for medical devices

Also Published As

Publication number Publication date
CA2466103C (en) 2010-06-15
DE60225844D1 (de) 2008-05-08
US20040013717A1 (en) 2004-01-22
WO2003037295A3 (en) 2004-07-29
ES2306785T3 (es) 2008-11-16
DE60225844T2 (de) 2009-04-09
EP1465590B1 (de) 2008-03-26
EP1465590A2 (de) 2004-10-13
CA2466103A1 (en) 2003-05-08
AU2002336867A1 (en) 2003-05-12
WO2003037295A2 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
PL360262A1 (pl) Kompozycje polimerycznych micelli
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
EE05074B1 (et) Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
MXPA05002814A (es) Formulacion para agentes lipofilicos.
CO5590918A2 (es) Formulaciones
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BRPI0407181A (pt) Formulação farmacêutica
DK1079807T3 (da) Anvendelse af præparater til tilförsel af antiseptiske midler og/eller midler, som fremmer heling af sår, til de nedre luftveje
HUP0301349A2 (hu) IL-11-tartalmú készítmények
EE200200625A (et) Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena
DK1392254T3 (da) Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
DE60225844D1 (de) Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
GB2446341A (en) Method and system for transdermal drug delivery
MXPA04005552A (es) Analogos de vitamina d.
PL368686A1 (en) Novel aminobenzoephenones
ATE353231T1 (de) Pharmazeutische zusammensetzungen
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
HUP0400737A2 (hu) L-karnitin alkalmazása proteinek stabilizálására szolgáló készítmények előállítására
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties